For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
No more ‘more of the same’: Minister stares into health sector’s gaping abyss
+Print Archive
POLICY PUZZLER
No more ‘more of the same’: Minister stares into health sector’s gaping abyss
Wednesday 20 June 2018, 05:00 AM

Staring into the abyss
Health-sector reform is on the cards but, whether swingeing or incremental, it has always been problematic, writes Tim Tenbensel. Can the latest review find the sweet spot?
The challenge is to balance the imperatives of economies of scale with local responsiveness and capacity for collaboration
Health minister David
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.